ANP32E induces tumorigenesis of triple-negative breast cancer cells by upregulating E2F1

Molecular alterations in triple-negative breast cancer—the road to new treatment strategies

(2017) Carsten Denkert et al.   LANCET

Downregulation of miRNA-141 in breast cancer cells is associated with cell migration and invasion: involvement of ANP32E targeting

(2017) Ping Li et al.   Cancer Medicine

Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast Cancer

(2016) Kelly K. Hunt et al.   CLINICAL CANCER RESEARCH

CRISPR gene-editing tested in a person for the first time

(2016) David Cyranoski   NATURE

Chromatin remodeling gene ARID2 targets cyclin D1 and cyclin E1 to suppress hepatoma cell progression

(2016) Yujie Duan et al.   Oncotarget

Upregulation of E2F8 promotes cell proliferation and tumorigenicity in breast cancer by modulating G1/S phase transition

(2016) Liping Ye et al.   Oncotarget

Predictors of Chemosensitivity in Triple Negative Breast Cancer: An Integrated Genomic Analysis

(2016) Tingting Jiang et al.   PLOS MEDICINE

Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer

(2016) Jingdan Qiu et al.   Journal of Cancer

Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial

(2015) Rajendra Badwe et al.   LANCET ONCOLOGY

Targeting a cell state common to triple-negative breast cancers

(2015) M. K. Muellner et al.   Molecular Systems Biology

Histone chaperone Anp32e removes H2A.Z from DNA double-strand breaks and promotes nucleosome reorganization and DNA repair

(2015) Ozge Gursoy-Yuzugullu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

DEC1 regulates breast cancer cell proliferation by stabilizing cyclin E protein and delays the progression of cell cycle S phase

(2015) H Bi et al.   Cell Death & Disease

Cyclin E1 and RTK/RAS signaling drive CDK inhibitor resistance via activation of E2F and ETS

(2015) Barbie Taylor-Harding et al.   Oncotarget

Anp32e, a higher eukaryotic histone chaperone directs preferential recognition for H2A.Z

(2014) Zhuo Mao et al.   CELL RESEARCH

ANP32E is a histone chaperone that removes H2A.Z from chromatin

(2014) Arnaud Obri et al.   NATURE

Overexpression of AKIP1 promotes angiogenesis and lymphangiogenesis in human esophageal squamous cell carcinoma

(2014) C Lin et al.   ONCOGENE

Loss of NDRG2 expression activates PI3K-AKT signalling via PTEN phosphorylation in ATLL and other cancers

(2014) Shingo Nakahata et al.   Nature Communications

Discovery of Biomarkers Predictive of GSI Response in Triple-Negative Breast Cancer and Adenoid Cystic Carcinoma

(2014) A. Stoeck et al.   Cancer Discovery

Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells

(2013) Ophir Shalem et al.   SCIENCE

Clinical relevance of TNM staging system according to breast cancer subtypes

(2011) Y. H. Park et al.   ANNALS OF ONCOLOGY

Role of Leucine-Rich Repeat Proteins in the Development and Function of Neural Circuits

(2011) Joris de Wit et al.   Annual Review of Cell and Developmental Biology

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Knockdown of FLOT1 Impairs Cell Proliferation and Tumorigenicity in Breast Cancer through Upregulation of FOXO3a

(2011) C. Lin et al.   CLINICAL CANCER RESEARCH

Control of Drosophila endocycles by E2F and CRL4CDT2

(2011) Norman Zielke et al.   NATURE

Nitric oxide and protein phosphatase 2A provide novel therapeutic opportunities in ER-negative breast cancer

(2011) Christopher H. Switzer et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Deregulation of the cell cycle by breast tumor kinase (Brk)

(2010) Edward Chan et al.   INTERNATIONAL JOURNAL OF CANCER

Triple-Negative Breast Cancer

(2010) William D. Foulkes et al.   NEW ENGLAND JOURNAL OF MEDICINE

Unregulated miR-96 Induces Cell Proliferation in Human Breast Cancer by Downregulating Transcriptional Factor FOXO3a

(2010) Huanxin Lin et al.   PLoS One

New Molecular Classifications of Breast Cancer

(2009) M. Cianfrocca et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

(2009) Maggie C. U. Cheang et al.   JNCI-Journal of the National Cancer Institute

A Six-Gene Signature Predicting Breast Cancer Lung Metastasis

(2008) T. Landemaine et al.   CANCER RESEARCH

Astrocyte Elevated Gene-1 is a Novel Prognostic Marker for Breast Cancer Progression and Overall Patient Survival

(2008) J. Li et al.   CLINICAL CANCER RESEARCH

Cyclin-dependent kinases and cell-cycle transitions: does one fit all?

(2008) Helfrid Hochegger et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY